Crossmark

ASO Author Reflections: Toward Personalized Neoadjuvant Therapy in HER2-Positive Breast Cancer—A Clinically Actionable Predictive Model

Published Online: 2026-02-27

Authors

Jiang, Xiaoliu

Huang, Zhaohui

Cao, Yali

Ding, Jingxian
License Information

Text and Data Mining valid from 2026-02-27

Version of Record valid from 2026-02-27
More Information

Article History

Received: 2 February 2026

Accepted: 2 February 2026

First Online: 27 February 2026

Disclosure

: The authors declare that they have no competing interests.

Document is current